Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 7 | 2020 | 89 | 0.890 |
Why?
|
| Students, Medical | 2 | 2020 | 435 | 0.850 |
Why?
|
| Embolization, Therapeutic | 6 | 2025 | 272 | 0.840 |
Why?
|
| Vena Cava, Inferior | 7 | 2020 | 139 | 0.800 |
Why?
|
| Career Choice | 2 | 2020 | 156 | 0.670 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2024 | 418 | 0.670 |
Why?
|
| Device Removal | 6 | 2020 | 168 | 0.620 |
Why?
|
| Medicine | 1 | 2020 | 95 | 0.600 |
Why?
|
| Liver Neoplasms | 5 | 2024 | 776 | 0.580 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 557 | 0.430 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 660 | 0.420 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 135 | 0.400 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 62 | 0.350 |
Why?
|
| Radiography, Interventional | 5 | 2020 | 148 | 0.320 |
Why?
|
| Renal Dialysis | 3 | 2021 | 350 | 0.320 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 53 | 0.310 |
Why?
|
| Pulmonary Embolism | 3 | 2020 | 226 | 0.300 |
Why?
|
| Catheter Ablation | 2 | 2022 | 345 | 0.280 |
Why?
|
| Yttrium Radioisotopes | 3 | 2024 | 47 | 0.260 |
Why?
|
| Angioplasty | 2 | 2019 | 68 | 0.240 |
Why?
|
| Treatment Outcome | 16 | 2025 | 9099 | 0.240 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 242 | 0.240 |
Why?
|
| Tumor Burden | 2 | 2024 | 321 | 0.240 |
Why?
|
| Angiography | 3 | 2021 | 192 | 0.230 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 119 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2025 | 49 | 0.210 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 164 | 0.210 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 43 | 0.210 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 80 | 0.210 |
Why?
|
| Pulmonary Veins | 1 | 2025 | 104 | 0.200 |
Why?
|
| Microspheres | 1 | 2024 | 88 | 0.200 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 91 | 0.200 |
Why?
|
| Hepatectomy | 1 | 2024 | 177 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2025 | 333 | 0.190 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 203 | 0.190 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2022 | 32 | 0.180 |
Why?
|
| Workload | 2 | 2020 | 126 | 0.180 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2802 | 0.170 |
Why?
|
| Humans | 28 | 2025 | 93515 | 0.170 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2021 | 10 | 0.170 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2021 | 16 | 0.170 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 31 | 0.170 |
Why?
|
| Hospital Units | 1 | 2020 | 29 | 0.160 |
Why?
|
| Female | 17 | 2025 | 48702 | 0.160 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 23 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 60 | 0.160 |
Why?
|
| Hepatic Artery | 1 | 2021 | 82 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 2020 | 52 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 57 | 0.160 |
Why?
|
| Time Factors | 7 | 2025 | 5410 | 0.160 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 37 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 78 | 0.160 |
Why?
|
| Brachytherapy | 1 | 2021 | 126 | 0.150 |
Why?
|
| Work-Life Balance | 1 | 2019 | 7 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1531 | 0.150 |
Why?
|
| Retrospective Studies | 11 | 2024 | 10164 | 0.140 |
Why?
|
| Sexism | 1 | 2019 | 56 | 0.140 |
Why?
|
| Mentors | 1 | 2019 | 98 | 0.140 |
Why?
|
| Social Media | 1 | 2020 | 111 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2021 | 713 | 0.130 |
Why?
|
| Medicare | 1 | 2021 | 455 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2019 | 288 | 0.130 |
Why?
|
| Motivation | 1 | 2020 | 310 | 0.130 |
Why?
|
| Male | 14 | 2025 | 44557 | 0.130 |
Why?
|
| Middle Aged | 13 | 2025 | 27573 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2021 | 1118 | 0.130 |
Why?
|
| Risk Factors | 6 | 2025 | 5899 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 621 | 0.120 |
Why?
|
| Fluoroscopy | 3 | 2024 | 129 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1105 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 452 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.120 |
Why?
|
| Stents | 2 | 2020 | 409 | 0.110 |
Why?
|
| Prosthesis Design | 4 | 2019 | 297 | 0.110 |
Why?
|
| Aged | 11 | 2024 | 20434 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 123 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 7061 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2562 | 0.100 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 101 | 0.100 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 111 | 0.090 |
Why?
|
| Endoleak | 1 | 2012 | 42 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 60 | 0.090 |
Why?
|
| Young Adult | 5 | 2025 | 6930 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 120 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 257 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2025 | 2441 | 0.080 |
Why?
|
| Adult | 8 | 2025 | 27918 | 0.080 |
Why?
|
| Chicago | 3 | 2019 | 1464 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 9606 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 882 | 0.060 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 207 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2013 | 1194 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 429 | 0.060 |
Why?
|
| Phlebography | 2 | 2016 | 68 | 0.050 |
Why?
|
| SEER Program | 1 | 2024 | 235 | 0.050 |
Why?
|
| Operative Time | 1 | 2024 | 167 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 178 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 49 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2021 | 37 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3830 | 0.040 |
Why?
|
| Microwaves | 1 | 2021 | 32 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 179 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 104 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 53 | 0.040 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 90 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7622 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 72 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1922 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 37 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 124 | 0.040 |
Why?
|
| Contrast Media | 1 | 2024 | 988 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 156 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 229 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 128 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 151 | 0.030 |
Why?
|
| Aspirin | 1 | 2019 | 167 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2020 | 220 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2585 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2715 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 254 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 249 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 608 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 920 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1190 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 457 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1448 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1917 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 168 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 75 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1948 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1701 | 0.020 |
Why?
|